Blue Print Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 0.97 Cr
as on 26-06-2024
- Company Age 33 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 362.63%
(FY 2021)
- Profit 384.31%
(FY 2021)
- Ebitda 243.48%
(FY 2021)
- Net Worth 1.71%
(FY 2021)
- Total Assets 16.07%
(FY 2021)
About Blue Print Pharmacy
The Corporate was formerly known as Prajapati Mercandise Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pushpa Agarwal, Suresh Agarwal, and Vivek Agarwal serve as directors at the Company.
- CIN/LLPIN
U24100WB1991PTC052626
- Company No.
052626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Blue Print Pharmacy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpa Agarwal  | Director | 14-Jan-1999 | Current |
| Suresh Agarwal | Director | 14-Jan-1999 | Current |
| Vivek Agarwal | Director | 20-Aug-2019 | Current |
Financial Performance and Corporate Structure Insights of Blue Print Pharmacy.
Blue Print Pharmacy Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 362.63% increase. The company also saw a substantial improvement in profitability, with a 384.31% increase in profit. The company's net worth moved up by a moderate rise of 1.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Print Pharmacy?
In 2020, Blue Print Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Manshya Agro Private Limited
Active
11 years 11 months Pushpa Agarwal, Suresh Agarwal and 1 more are mutual person
Ikshita Agrotech Private Limited
Active 11 years 3 months Pushpa Agarwal and Vivek Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blue Print Pharmacy?
Blue Print Pharmacy has a workforce of 4 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jul 23, 2009, Blue Print Pharmacy has raised a total of ₹ 1.4 M, with the most recent deal valued at ₹ 0.7 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
